The engineering of biological substitutes and strategies for the replacement and/or repair of blood vessels and the components of the heart represents an important challenge for tissue engineering. In this review, the progress to date and the barriers remaining are addressed. Even though the progress has been considerable and there are even some approaches that have entered clinical trials, we are still a ways off from having FDA-approved replacements and/or repair strategies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1600-6135.2004.0343.x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!